Home|Journals|Articles by Year|Audio Abstracts

Original Research

Relationship among expression of E-cadherin and HER-2/neu with metastasis in breast cancer

Yendri Januardi, Djonny Ferianto Pualilin, Indra Kadir, Prihantono Prihantono.

Cited by 1 Articles

Breast cancer was a type of malignancy that occurred in human breast organs in both ductal and lobule tissues. In Indonesia, more than 80% of the cases were found in an advanced stage, as prognosis became worse and therapy effectiveness was less. It was estimated, as many as 40% of Breast cancer patients died of metastatic factors. Therefore, examination of prognostic biomarkers of metastasis in breast cancer was critical. This study aimed to examine the relationship between the expression of E-cadherin and Her-2 /Neu with the incidence of distant metastases in breast cancer. This study was conducted using analytical observation method with cross-sectional study in 46 breast cancer patients who were both metastatic and not metastatic breast cancer patients at Dr. Wahidin Sudirohusodo Hospital Makassar. Research results showed that there was no significant relationship between tumor grading and incidence of metastasis (p> 0.05), but it was seen that the percentage of subjects with M1 was found to be higher at a moderate grade (69.2%) and high grade (46.7%) compared on low grade (40.0%). Also, it is known that there was a significant relationship between E-Cadherin expression and incidence of metastasis (p

Key words: E-cadherin, HER-2 / NEU, breast cancer, metastasis

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.